Source link : https://www.newshealth.biz/health-news/clozapines-rems-program-on-the-chopping-block-at-upcoming-fda-meeting/
Is a risk evaluation and mitigation strategy (REMS) still needed for clozapine? That’s what a joint meeting of two FDA advisory committees will discuss on Tuesday. Risk management requirements for the atypical antipsychotic have evolved in the past 35 years to a REMS that manages the risk of severe neutropenia, which can lead to serious […]
Author : News Health
Publish date : 2024-11-15 22:42:33
Copyright for syndicated content belongs to the linked Source.
